Bone Marrow Transplantation (2018) 53:366–370 https://doi.org/10.1038/s41409-017-0032-1 CORRESPONDENCE Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma 1 1 2 2 2 1 ● ● ● ● ● ● Jacopo Mariotti Stefania Bramanti Raynier Devillier Sabine Furst Jean El Cheikh Barbara Sarina 2 2 2 1 2 ● ● ● ● ● Angela Granata Catherine Faucher Samia Harbi Lucio Morabito Pierre Jean Weiller 3,4,5 6 7 1,8 1,9 ● ● ● ● ● Christian Chabannon Jamel Mokart Rossana Mineri Carmelo Carlo-Stella Armando Santoro 2,4,5 1 Didier Blaise Luca Castagna Received: 25 May 2017 / Revised: 17 September 2017 / Accepted: 18 September 2017 / Published online: 21 December 2017 © Macmillan Publishers Limited, part of Springer Nature 2018 Introduction autologous transplant for high-risk patients according to the SFGM score, showing a 5-year PFS and OS of 46 and 57%. High dose chemotherapy (HDCT) followed by autologous A sequential program was previously shown to be fea- stem cell transplantation in chemorefractory Hodgkin lym- sible and effective for resistant HL with a 2-year event free phoma (HL) patients resulted in a disappointing long-term survival (EFS) of approximately 50% . We have found progression-free survival (PFS) lower than 30–40%
Bone Marrow Transplantation – Springer Journals
Published: Dec 21, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera